Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|February 1, 2016
- Pharmaceutical Technology-02-02-2016
- Volume 40
- Issue 2
Crossflow Filtration System for Process Development
Sartorius Stedim Biotech’s (SSB) Sartoflow Smart is a benchtop crossflow system for optimized ultra- and diafiltration applications.
Sartorius Stedim Biotech’s (SSB) Sartoflow Smart is a benchtop crossflow system for optimized ultra- and diafiltration applications. The system can be used in downstream processes, such as purification of vaccines, monoclonal antibodies, and recombinant proteins. The system is suitable for flexible use in laboratory environments for process development, clinical trials, and cGMP environments.
The system is equipped with a low shear 4-piston membrane pump that provides a wide range of flow rates. Users can select membrane surface areas from 50 cm² to 0.14 m². An optional peristaltic diafiltration pump is available to load product or buffer as a discrete process step. The system can be customized: conductivity, pH, or temperature probe can be installed in the recirculation vessel. The system can also be upgraded in the case of changing process requirements.
www.sartorius.us
Articles in this issue
over 10 years ago
Preventing Film Coating Problems by Designover 10 years ago
Going Small to Achieve Commercial-Scale Successover 10 years ago
Innovating for Innovationover 10 years ago
Faster, Cheaper, and Greenerover 10 years ago
Macro Mattersover 10 years ago
Innovative Therapies Require Modern Manufacturing Systemsover 10 years ago
Creating Robust CAPA Systemsover 10 years ago
Measurement Uncertainty without the Mathover 10 years ago
Pharmaceutical Technology, February 2016 Issue (PDF)over 10 years ago
Vacuum De-aeration ApparatusRelated to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.